Sleep complaints are frequent in patients with rheumatoid arthritis (RA) and sleep disturbances may contribute to pain and other daytime complaints. The aims of the current study were to compare ambulatory sleep recordings from consecutively selected patients with RA to those obtained in healthy controls, and to study the relationships between sleep structure and clinical symptoms. Sleep recordings were obtained from 41 out-patients with RA and 19 matched controls. All had clinical examinations and completed dierent questionnaires. Recordings were scored traditionally and, moreover, the electroencephalography (EEG) was subjected to frequency analysis. For the study of sleep±wake interactions in the patients, a graphical chain model was used. The patients had many sleep-related complaints. An increase in the number of periodic movements of the legs (PML) during sleep was seen in comparison with controls, but otherwise only minor dierences were observed in classical sleep stages. Data from frequency analysis showed an increase in alpha (8±12 Hz)-EEG activity in sleep stages non-rapid eye movement (NREM) 2±4 in most sleep cycles. The statistical model demonstrated a complex but independent correlation between morning stiness, pain and joint tenderness on the one hand, and awakenings, stage NREM2, slow-wave sleep and stage REM on the other, probably re¯ecting a relationship between sleep patterns and pain in RA. In conclusion, only the increase in PML and alpha-EEG activity distinguished the sleep in RA patients from that of healthy controls. However, the demonstrated interaction between daytime complaints and sleep patterns may increase the understanding and treatment of the disease. In future research, graphical chain models may improve our understanding of complex relationships between multiple variables.
SLEEP problems are frequent in medical illness [1±4] , and an association between sleep and morbidity, as well as mortality, has been demonstrated [5, 6] . Pain especially may be a leading cause of insomnia in medical patients [4, 7] , but on the other hand, disturbances in sleep may also alter the pain threshold [8] . Finally, the disease process per se, as well as medication, may in¯uence the sleep process [2, 9] . Accordingly, in most studies, sleep disturbances have been reported by more than half of the patients with rheumatoid arthritis (RA) [10±13] . As sleep disorders may contribute to various daytime symptoms such as fatigue, stiness and pain [9, 12±17] , studies of sleep may have the potential to increase our knowledge of the natural history of the disease. Among other ®ndings, polysomnographic (PSG) recordings have documented a high prevalence of sleep fragmentation, alpha-electroencephalographic (EEG) activity and primary sleep disorders in a limited number of patients [9, 13±15, 18±20] . In some of these studies, the subjects selected had either an exacerbation of the disease [13] or complained of very early onset of fatigue [15] . Moreover, a control group was only included in one previous study [9] . Finally, most PSG studies of sleep in RA were based on recordings obtained in the sleep laboratory. Under these circumstances, sleep may not be natural, unless several nights are used for adaptation to the laboratory. Even then, some subjects may have problems with sleeping in non-familiar surroundings [21] . To address these problems, the current study was performed. The aims were 3-fold. Firstly, to compare the classical sleep stages from recordings obtained at home in non-selected out-patients with RA to those from healthy subjects. Secondly, to study sleep microstructure using power spectral analysis and, ®nally, to address sleep/wake interactions using multivariate statistics based on graphical chain models. study was approved by the local ethics committee. In one subject, the sleep recording failed due to technical problems, and the patient did not wish to reenter the study. Nineteen age-and sex-matched healthy subjects served as controls.
Assessments
All patients were classi®ed according to their functional status [23] . A clinical examination was performed on the evening before the sleep recordings. The number of swollen and tender joints and the Ritchie Articular Index [24] were calculated. All tender points normally used in the assessment of ®bromyalgia were palpated. Evaluation of the duration of morning stiness and a three-point physical activity scale were also completed, and the erythrocyte sedimentation rate was measured. Mean daytime sleepiness was measured using a 0±100 mm visual analogue scale ranging from`no sleepiness' tò worst imaginable sleepiness', and pain intensity was assessed on a 1±5 verbal scale [25] . For sleepiness and pain, the mean of the score on the day the PSG was performed and the score the following day was calculated. Finally, the following questionnaires were completed before the PSG: the modi®ed Stanford Health Assessment Questionnaire (HAQ) with scores ranging from 0 (best possible) to 24 (worst possible) [26] , the Danish version of the McGill Pain Questionnaire (MPQ) [25] , a nine-item fatigue scale, all items with scores ranging from 1 (worst possible) to 7 (best possible) [27] , and the Basic Nordic Sleep Questionnaire (BNSQ) based on 1 (best possible) to 5 (worst possible) verbal scales [28] .
Sleep recordings
All subjects had home PSG recordings performed on two consecutive nights. As a minimal`®rst night eect' has been demonstrated using the equipment [29] , the ®rst night served as a practice run, and only data from the second night were stored for further analysis. The collecting system was designed for direct sampling of all polygraphic data at the bedside and its reliability as well as technical speci®cations have been documented previously [29] . The montage consisted of two EEG leads (F1±A2, C4±A1), electro-oculography (EOG) (left eye±A2, right eye± A2), submental electromyography (EMG), bilateral anterior tibial EMG and a respiratory belt. All psychotropic drugs were withdrawn 2 weeks before the study [30] , but otherwise patients were on their regular medication. Subjects were only allowed to smoke and drink tea or coee until 6 p.m. the same day. After applying the electrodes, the head box was disconnected from the main ampli®er and placed in a belt. The subjects were allowed to move around freely until their usual bedtime, and they were instructed how to start the recordings themselves by pressing a button on the recording system when the light was turned o. They were allowed to get out of bed during the night if necessary and to get up at the usual time. In the morning, the recordings were stopped by pressing another button on the system and subjects removed the electrodes themselves. The maximum recording time was set at 9 h in case the computer was not stopped by the patient.
All PSG data were scored manually and blindly by the same physician in 30 s epochs according to standard criteria [31] . The Nightingale system (Judex Datasystems A/S, Aalborg, Denmark) was used for display of polygraphic signals. The sleep period was the time from the onset of non-rapid eye movement (NREM) stage 1 until ®nal awakening. Total sleep time was de®ned as the time spent in stages NREM1±4 + rapid-eye-movement (REM) sleep. Sleep eciency was de®ned as total sleep time as a percentage of sleep period, and slow-wave sleep (SWS) was NREM3 and 4 combined. Total time spent in stage wake (Wake) included sleep latency and all epochs scored as Wake until ®nal awakening. Arousals were scored according to Bonnet et al. [32] . Apnoeas and hypopnoeas were analysed [33] , and leg movements were detected as increased activity in one or both tibial EMG channels with or without simultaneous arousal [34] . Periodic movements of the legs (PML) [35] were scored separately. The number of arousals (Arousal Index), apnoea/hypopnoeas (Apnoea Index), leg movements (Movement Index) and PML (PML Index) per hour were calculated. No attempt was made to score the alpha-EEG visually, as quanti®cation was performed using frequency analysis.
Frequency analysis
The F1±A2 derivation was selected for frequency analysis. This lead has been shown to be the most stable and noise free in home recordings compared to the C4±A1 derivation [29] . Epochs labelled as artefacts, Wake or movement time were discarded from analysis. The EEG was pre-emphasized 20 dB/ decade to expand the amplitudes at high frequencies [36] , and frequency analysis of the EEG was performed using autoregressive (AR) modelling [37] . The sleep EEG was divided into ®ve frequency bands, delta (0.5±3.5 Hz), theta (3.5±8 Hz), alpha (8±12 Hz), sigma (12±14.5 Hz) and beta (14.5±25 Hz), and for every 2 s segment of the EEG the distribution of normalized power was calculated in these ®ve bands [37] . Finally, the mean power for every 30 s epoch was computed and the power for all sleep stages calculated individually. As sleep appears in 4±6 ultradian NREM/REM cycles throughout the night [39] , the analysis was also performed for each sleep cycle. To compute the total amount of power in the delta and alpha bands in every sleep cycle, a calculation was performed where the number of epochs as well as the density of power were taken into consideration. Therefore, in each sleep cycle, the mean power in the two bands was multiplied by the number of epochs in each of the stages NREM2±4 individually and ®nally summarized to give the total power normalized for each cycle [38] .
Statistics
Comparison of patients and controls. The variables were described by the mean and S.D. Data from conventional sleep staging in patients and controls were compared using t-tests. As mainly sleep stages NREM2±4 are thought to re¯ect homeostatic processes, the distribution of the EEG power in these stages was calculated using two-way analysis of variance (ANOVA), where power in the individual frequency bands entered as the dependent variable and sleep stage (NREM2±4) and type (patient versus control) entered as factors.
Relationship between clinical variables. The many parameters and preliminary statistical analysis indicated a complex relationship between the individual variables. As no a priori knowledge of the relationship between the variables was given, a model with only stochastic relationships was a proper choice. Therefore, a graphical chain model was selected for ®nal analysis and interpretation of data. The graphical chain models [40] have previously been found to be valuable for discovering and describing structures in a complex, stochastic system. A graphical model for discrete variables, i.e. contingency tables, is a log±linear interaction model that can be represented by a simple graph with as many points as there are dimensions in the table. These models can be given an interpretation in terms of conditional independencies which can be read o the graph (in the form of a Markov property). Thus, hypotheses are formulated about relationships of variables, using points for variables and lines for each pair of variables having some relationship. Most importantly, a missing line corresponds to the conditional independence of the two variables in case. The computational method had a multivariate design, where the starting point was à full model', i.e. a model with all possible connections between the variables. To identify a minimal and unique model, backward elimination and forward selection were used. Elimination and selection refer to removing or adding a line during an interactive process. Whether a line should be removed (or added) is based on a likelihood ratio test using exact P values, where the model including the line is tested against the model without the line. Following the ®rst calculations, a retesting of all variables was performed where the new information obtained was included in the model. This testing was carried out an inde®nite number of times until stability of the system was reached. If a signi®cant relationship between variables was reached at a signi®cance level of 0.05, this was indicated by a line. The line thus shows a signi®cant relationship between two variables independent of the multiple relationships between the others, i.e. a change in one parameter is followed by a change in the other [41] . Finally, all variables and the relationships between them were described in a graphical presentation referred to as the`initial model'.
As data should be represented by a contingency table, they were divided into levels dependent on the actual values if these were discrete. Some values were merged into one level if there were too few data within this level to ensure validity of the likelihoodratio tests. Continuous variables, however, were divided into three levels using the 33 and 66% percentiles. This reduction was necessary to ensure a reasonable amount of data for each level of a given variable. The following parameters were selected for inclusion in the model: type [RA/N (normal)], sex, duration of disease, HAQ score, morning stiness, Ritchie and pain scores, erythrocyte sedimentation rate, fatigue and sleepiness scores, physical activity score, sleep quality, percentage time spent in stage Wake, NREM1±4 and REM, number of stage shifts, Arousal and Movement Index, and normalized power in the ®ve frequency bands in stage NREM2±4 merged.
In the next step, a subset of variables was selected. The reason for the reduction was ®rstly that the initial model was too complex to give any clear interpretation of the data and, secondly, that the amount of data was too small to ensure a unique model, i.e. the number of variables has to match the amount of data. According to the relationships seen in the initial model and a selection of the variables which have previously been focused on in sleep/wake interactions, the procedure included the following 15 variables: type, duration of disease, pain level, Ritchie score, morning stiness, time spent in stage Wake, NREM2, SWS and REM, number of stage shifts, Arousal Index and power in delta, theta, alpha and sigma bands. The relationships between variables in the re®ned system were computed using the methods described above. In the presentation of the ®nal model, a causal probabilistic network (CPN) shell was implemented (Hugin Expert A/S, Aalborg, Denmark). Using this shell, routines are available for the calculation and presentation of marginal densities, i.e. the percentage distribution within each level of a given variable [42] . Thus, complex relationships between sleep/wake interactions could ®nally be simulated and dynamic examples for the use of the system presented.
RESULTS

Clinical and demographic data
Forty-one patients with RA completed the study. These were 11 males and 30 females, mean age 53.2 yr (13.9). None had other medical diseases or disorders known to interfere with sleep. The mean duration of disease was 162 months (114.0) and the mean Steinbrocker Index was 1.6 (0.8). Erythrocyte sedimentation rate was 22.3 (14.3) . The number of swollen and tender joints was 9.6 (9.0) and 5.8 (6.1), respectively, and the tender point count was 5 (5.5). Mean Ritchie score was 14.4 (12.3). Morning stiness was 64.5 min (77.3) and the physical activity score was 1.6 (0.5). Mean fatigue score was 2.7 (1.3) and sleepiness score 48.0 (24.9). Mean daytime pain intensity was 1.8 (1.0) and from the MPQ the Total Pain Rating Index was 18.5% (15.6%). The mean HAQ score was 6.1 (5.0). Medical treatment was second-line agents in 26 patients, 32 received analgesics and eight corticosteroids.
Controls were four men and 15 women, mean age 55.5 yr (17.5). All were healthy without any musculoskeletal symptoms and they had no complaints of pain, fatigue, sleepiness, etc.
For the subjective sleep complaints, selected data from the BNSQ are seen in Table I . Patients with RA had more diculty falling asleep and more frequently felt that they had sleep problems. À non-restorative' sleep pattern and more daytime sleepiness were also seen in the patient group.
Polysomnography
Data from conventional sleep staging are seen in Table II . There was a tendency towards more stage shifts (P = 0.07) in the RA group and PML were more frequent among the patients (P = 0.05), but otherwise no signi®cant dierences were seen. When comparison of time spent in absolute minutes was made for the sleep stages (data not shown), the patients spent more time in stage NREM3 (44.8 vs 35.6 min; P = 0.05).
When a subset of 17 patients having active disease was de®ned (ful®lling three of the following four criteria: number of swollen joints e3, number of tender joints e6, duration of morning stiness >45 min and erythrocyte sedimentation rate >28), no dierences in PSG parameters were observed in comparison with those patients having less active disease (data not shown).
Frequency analysis
In two subjects with RA and in one control, the technical quality of the recordings did not allow frequency analysis and they were omitted from the calculations. The distribution of power in the ®ve frequency bands was calculated for a total of H700 000 2-s epochs (Table III) . Patients with RA had more power in the alpha band in sleep stages NREM2±4 combined in comparison with controls (F = 5.6, P = 0.02), but no dierences in power were seen in the other frequency bands. Data from the analysis in sleep cycles are shown in Table IV . For cycle 4, only six patients and three controls spent time in NREM3 and 4, and therefore data for these stages were omitted. Six controls and 15 patients slept in cycle 5, but due to the small number of epochs spent in this cycle (most of these subjects had their ®nal awakening here), data were excluded from analysis. For individual sleep cycles, the patients had more alpha power in stage NREM2±4 in cycles 1, 2 and 4 [F = 6.9, P = 0.01; F = 4.6, P = 0.03 and P = 0.05 (t-test), respectively] and controls had more power in the beta band in cycle 1 (F = 4.7, P = 0.03).
The decline in total amount of delta power during sleep cycles followed the expected exponential curve [43] in both groups and no dierences were observed. Total alpha power followed a more horizontal line, but again no signi®cant dierences were observed between the groups.
Correlations
Interactions between clinical and sleep variables in the initial model are shown in Fig. 1 . As expected, signi®cant associations were found between most clinical scores, and correlations were also demonstrated between several sleep variables. When the relationships between individual variables were taken into account, variables such as fatigue, HAQ, physical activity and sleepiness did not correlate with sleep parameters, and the individual frequency bands also showed very weak interactions with the other variables. Because of the relatively small amount of data in comparison with the many variables, the initial model was too unstable to draw any ®nal conclusions on the relationships. The tendencies were, however, used in an objective selection of variables to be used in the ®nal model, as stated in the Methods. After stability of the system was reached in the ®nal model, many variables did not in¯uence the system and these were excluded during processing. Furthermore, the relationship between some variables was modi®ed after simpli®cation of the model due to the information lost in the eliminated data (normally referred to as Simpson's paradox). The model found from the data is shown in Fig. 2 and Table V , ®rst row. The two pain parameters were related to morning stiness, which was shown to have a central role, being the most explanatory variable to predict the sleep pro®le. The interactions of the individual variables could then be studied dynamically using the CPN routines. The general impression was that an independent interaction between disease activity measured by morning stiness, pain and Ritchie score on the one hand, and time spent in stage Wake, NREM2 and SWS on the other, exists. These ®ndings are illustrated in the following simulated examples (Table V) . Example 1. A patient with maximal pain (=level 4). As seen in Table V (second row), a deterioration in morning stiness and Ritchie score was seen (as expected) in comparison with the baseline distribution shown in the ®rst row in Table V . A decrease in time spent in stage Wake and NREM2 was also observed with an increase in SWS. When the pain level was minimal, corresponding to level 1 (data not shown), a decrease in stage Wake was also seen, but SWS also decreased. Pain score at level 2 (not shown) was followed by an increase in time spent in stage Wake without major changes in SWS and stage REM.
Example 2. A patient with a high pain level as well as a long duration of morning stiness (Table V, Table V , fourth row. As demonstrated, an increase in time spent in stage Wake was seen, but the alterations in stage NREM2 and SWS were comparable to those seen in the previous example. Correspondingly, an increase in Ritchie score alone increased only time spent in stage Wake (not shown).
Example 4. The eect of a change in sleep parameters. An increase in SWS only resulted in a slight increase in morning stiness and an alteration in the two other sleep parameters (Table V, ®fth row). An increase in SWS together with a decrease in REM, however, was correlated to a decrease in pain and morning stiness (not shown).
Example 5. Finally, a decrease in stage Wake was followed by a decrease in pain level, Ritchie score and morning stiness (Table V, sixth row).
DISCUSSION
Ambulatory recordings in non-selected patients with RA demonstrated an increase in the number of PML during sleep, but otherwise no major dierences in classical sleep stages were observed in comparison with healthy controls. However, when sleep microstructure was studied, the patients had more alpha-EEG sleep. The graphical chain model showed a strong association between morning stiness, pain and joint tenderness on the one hand, and sleep parameters, especially SWS and time spent awake, on the other, indicating important aspects of sleep/wake interactions.
Sleep macrostructure
Subjective sleep disturbances were prevalent in the patients. In RA, symptoms such as pain, fatigue and morning stiness may be related to disturbances in the restorative functions promoted by sleep [10±12, 16, 44] . No major dierences in sleep macrostructure, comparing patients and controls, were seen in this study, however. Although data are somewhat conicting, most previous papers have reported normal sleep architecture (i.e. classical sleep stages) in RA. Sleep physiology, however, was found to be disturbed in these papers as fragmented sleep (awakenings and arousals), movements and apnoeas tend to be prevalent in the patients [9, 13, 15, 18, 20] . The tendency towards more stage shifts in the RA group seen in this report might indicate more fragmentation of sleep, but on the contrary no dierences between the measures for arousals and awakenings were seen. In the current study, more PML were seen in the patients. This ®nding is in accordance with previous studies [9, 15, 20] . The clinical signi®cance is unknown, but increased PML have also been found in various other medical disorders, and may be related to a central dopaminergic imbalance caused by the disease [9] . In comparison with previous reports, our patients had a higher sleep eciency, spent more time in SWS and less time in stage Wake and NREM1. These ®ndings can probably be attributed to the ambulatory sleep recordings, allowing the subjects to sleep in their natural settings, thus giving a more normal sleep pattern [29] . In some previous studies, patients were highly selected [13, 15, 18] , most having a¯are in the disease or suffering from severe fatigue. In comparison with these studies, our patients might have less activity of the disease. However, when the material was divided into those having more or less active disease, no dierences were seen in the two groups. The same ®ndings were observed in a previous questionnaire-based study [12] . These results can probably be related to the strong correlation between the clinical variables making the statistical evaluation dicult. This further emphasizes the value of graphical chain models in the analysis of such complex data.
Sleep microstructure
A quantitative increase in alpha-EEG was seen in sleep microstructure and ®ndings were consistent in most sleep cycles. The alpha-EEG sleep, which is a relatively high-frequency activity superimposed on the normal EEG in NREM sleep stages [45] , has been hypothesized to re¯ect an internal arousal activity interfering with the normal homeostatic functions during sleep [8, 21, 46±48] . Although seen in several medical and psychiatric disorders, alpha sleep has especially been associated with the ®bromyalgia syndrome [46, 49] . In patients with RA where alpha sleep was prominent [13] , this has been attributed tò secondary ®bromyalgia' co-existing with the primary disease. In the current study, however, none of the patients ful®lled the criteria for ®bromyalgia [50] and the alpha sleep, being constant in most sleep cycles, seems also to be a prominent feature in RA. This has also been demonstrated in other studies [9, 15, 20] , although no quantitative analysis was performed. Whether the alpha sleep re¯ects an internal arousal activity disturbing normal sleep or is a non-speci®c epiphenomenon [51] cannot, however, be concluded from this study.
Power in the delta band is probably the best single marker for the sleep process [43] and, among other abnormalities, a decrease in the normal exponential unwinding of power in the low-frequency range during sleep has been reported in ®bromyalgia [38] . In RA, a normal decline of power in this band was seen and no disturbances in the sleep process were thus re¯ected. Therefore, sleep microstructure disturbances are probably more characteristic in patients with ®bromyalgia than in RA. Although speculative, this may be related to dierent pain mechanisms in the two diseases. Thus, RA patients may have nociceptive inputs mainly from peripheral tissue interfering with sleep macrostructure. The pain in ®bromyalgia, however, is thought to be of a more central origin [52] , probably mostly re¯ected in sleep microstructure abnormalities.
Sleep/wake interactions
Statistical methods. Several statistical methods are available for the generation of hypotheses on associations between variables. For multiple parameters, the models most commonly used in medical research are based on ordinary multiple regression. In these models, an assumption of a linear relationship between the variables is made. Normal distribution of one variable, given the other, is also assumed. Where non-linearity exists, models such as curvilinear or logistic regressions [53] have been used. The relationship between biological variables, however, is often unknown or even more complex than assumed in the models above. Also, when more variables in¯uence the structure of the system, the preliminary relationship between the variables is often not ful®lled during further analysis. In graphical chain models, no a priori assumptions on the distribution of data or the relationship between the variables are made. Instead, the models are based on a determination of the probability for a given association between two variables, when the in¯uence of all the other variables in the model is taken into account. An advantage is the visual presentation of relationships between variables [40] . Nevertheless, this model also has limitations. Firstly, in the current case, a reduction to three levels was performed for variables with a continuous distribution, as for example the amount of time spent in a sleep stage. This was necessary to balance the number of data (i.e. subjects included) to the amount of variables. Secondly, active selection of variables was necessary to simplify the structure for a ®nal interpretation of the results. However, this was mainly done on the basis of objective knowledge regarding the preliminary relationships which were found in the initial model.
Clinical variables and sleep. The interaction between the variables was rather complex, but all experiments in the model showed a tendency towards more time spent in SWS and less in NREM2, when a clinical deterioration was simulated. As time spent in stage REM is thought to be relatively independent of NREM stages, an increase in time spent in SWS will invariably change the relative amount of stage NREM2. NREM sleep stages, especially SWS, are thought to re¯ect restorative properties of sleep [3, 54±56] ; therefore, the relationship between the clinical parameters and this stage is interesting. Thus, patients with high disease activity, re¯ected in morning stiness, pain and joint tenderness probably need more SWS. Although questioned by Trachsel et al. [57] , in experimental models of disease SWS seems important, being positively correlated with improved survival for example [58] . Correspondingly, an intimate relationship between the immune system and SWS has been hypothesized [59, 60] . Finally, in diseases where the release of cytokines (as in RA) is thought to play a role, a correlation between these substances and SWS has been reported [61, 62] .
Pain and sleep disturbances may be intimately correlated and dierent sleep disturbances have been reported in association with pain. Thus, pain was reported to be a leading cause of insomnia in medical patients [4, 7] , and previous studies in patients with rheumatic diseases have shown an association between pain, on the one hand, and awakenings, movements, alpha-EEG, decreased sleep eciency and SWS on the other [7, 14, 19, 63±65] . Dierent sleep disturbances were also seen in patients with pain due to, for example, coronary heart disease [66±68]. In acute pain, e.g. in patients undergoing surgery, or in experimental pain in animals, fragmented sleep as well as a decrease in SWS and REM were reported, probably due to the pain and stress induced by the trauma [69±74]. The opposite eect on SWS in these studies and our ®ndings may be explained by dierent mechanisms in acute and chronic pain. Epidemiological studies con®rm an association between sleeping problems and pain [75] , especially pain related to arthritis [76, 77] . On the other hand, sleep disturbances per se may also increase pain and stiness, and selective SWS deprivation in healthy subjects has been shown to lower the pain threshold [8, 78] . Finally, in subjects with pain, decreased physical activity [7, 79] , as well as psychological factors [76, 80±82] , may contribute to the sleep disturbances, although pain itself seems to account for most of the variance in sleeping behaviour [7, 76] . Although pain was positively related to SWS in the current study, the strong interaction between the clinical variables must, however, be taken into account, and pain may also be considered as one of several measurements for disease activity. As demonstrated in Fig. 1 , an association between pain level and arousals was also seen. However, the preliminary relationship was not suciently strong to persist when the selection of variables was performed to construct the ®nal model. Sleep fragmentation, re¯ected in time spent in stage Wake (but not movements), was correlated to pain in the current model, but in a somewhat complex fashion. Moderate pain at level 2 increased time spent awake, whereas both maximal and minimal pain score decreased the time spent in this stage. An increase in Ritchie score, re¯ecting a more direct measurement for joint pain, was also correlated to increased time spent awake. Correspondingly, a decrease in Wake was followed by improvement in all clinical parameters. Whether pain aects time spent in stage Wake, or vice versa, cannot be concluded from this study, but both relationships probably exist.
Fatigue and sleepiness were not directly associated with sleep variables. This was surprising as fatigue is a major complaint in medical diseases [16, 26, 83, 84] , and clinical as well as experimental studies have shown a close relationship between sleep fragmentation and daytime fatigue and sleepiness [16, 85±87] . However, as shown in Fig. 1 , the relationship of fatigue and sleepiness to sleep disturbances may be mediated via variables such as pain and stiness, and probably do not directly interfere with sleep architecture.
Medication
Medication may in¯uence the sleep structure. A 2 week washout period was performed for antidepressants and/or benzodiazepines, but otherwise patients were on their normal medication. Corticosteroids especially have been thought to modify sleep and alterations in the normal ultradian secretion of this hormone may probably be caused by sleep disturbances. However, when a separate analysis of sleep parameters, as well as power in the individual frequency bands, was performed for patients receiving prednisone and those who did not, no systematic dierences were found. This was supported by ®ndings in a previous study in RA patients [15] . The heterogeneity in the consumption of analgesics and second-line agents in our material did not permit statistical analysis, but in previous studies in RA patients these drugs did not give changes in sleep structure [9, 20] . Therefore, we do not believe that medication in¯uenced the results.
CONCLUSION
An increase in PML and the alpha-EEG were the only parameters distinguishing the ambulatory sleep recordings in patients with RA from those in healthy controls. However, signi®cant relationships between morning stiness, pain and sleep patterns were demonstrated, thus con®rming the important interactions between sleep and daytime function in rheumatic diseases.
